Medroxyprogesterone Acetate Suspension has 1 known drug interaction based on U.S. FDA drug labeling data. 1 are classified as major interactions requiring close medical supervision. Notable interactions include combinations with Pegvaliase-Pqpz. Patients taking Medroxyprogesterone Acetate Suspension should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.
- Total
- 1
- Major
- 1
Major (1)
- Medroxyprogesterone Acetate Suspension + Pegvaliase-Pqpz— Concomitant use may cause hypersensitivity reactions including anaphylaxis. Two patients experienced hypersensitivity re…